Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 0311

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.52, p 0.148). This receipt's hash covers every field on it, plus the hash of receipt 310, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 0311
    16 Oct 2026, 21:45 UTC

    SLC2A13

    dopamine neurons, braak

    predictionSLC2A13 in dopamine neurons tracks Braak Lewy-body stage

    registeredca5969d4072a14fe

    discovery+0.52 p=0.148 n=9

    replication+0.62 p=0.074 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.52, p 0.148)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    4422f3a711e293a793b56eb0…
    follows 29244f210a23…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 0311: SLC2A13 in dopamine neurons, braak

power
full sample +0.48 (p 0.042, n 18), 95% CI +0.02 to +0.78. the interval excludes zero: something may be there, smaller than a half can see.
confounder
adjusted for sex: +0.47 (p 0.050, n 18). holds up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.48 (p 0.044, n 18). not the mix.
skeptic
leave-one-out range +0.42 to +0.67, sign flips 0; without severely affected donors +0.48 (p 0.042, n 18). robust.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for SLC2A13 in dopamine neurons.

case closed: nothing better to follow up.